16 Nov 2023 argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis Member news
15 Nov 2023 Orionis Biosciences announces first patient dosed in Phase 1 clinical trial of ORB-011 in patients with advanced solid tumors Member news
14 Nov 2023 SwiftPharma and PlantForm target blockbuster cancer drug with new contract manufacturing agreement for plant-made biosimilars Member news
10 Nov 2023 miDiagnostics announces collaboration with Galapagos to develop closed-flow, ultra-rapid CAR-T sterility test for its point-of-care CAR-T manufacturing platform Member news
31 Oct 2023 Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to Alfasigma Member news
25 Oct 2023 myNEO evolves into myNEO Therapeutics to reflect its new strategy to develop off the shelf cancer vaccine immunotherapeutics Member news
25 Oct 2023 4TISSUE strengthens leadership team by welcoming Chief Executive Officer (CEO) Benoit Moreaux, DVM, PhD, PMP Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
